Send to:

Choose Destination
See comment in PubMed Commons below
J Pept Sci. 2013 Aug;19(8):485-90. doi: 10.1002/psc.2525. Epub 2013 Jun 22.

Minimal killing unit of the mitochondrial targeting domain of Noxa.

Author information

  • 1Department of Biochemistry and Molecular Biology, Chosun University School of Medicine, 309 Pilmoondaero, Gwang-Ju, 501-759, Korea.


Noxa is a key player in p53-induced cell death via mitochondrial dysfunction, and the mitochondrial-targeting domain (MTD) of Noxa is responsible for the translocation of Noxa to mitochondria and for the induction of necrotic cell death. The purpose of this study was to define the minimal killing unit of MTD in vitro and in vivo. It was found that the peptides R8:MTD(10), R8:MTD(9), and R8:MTD(8) can kill various human tumor cells (HCT116, HeLa, MCF-7, BJAB), but that R8:MTD(7) abolishes the killing activity of MTD mainly because of the loss of mitochondrial targeting activity. We find it interesting that R8:MTD(8) was found to kill tumor cells but showed a limited killing activity on normal peritoneal macrophages. Furthermore, R8:MTD(10), R8:MTD(9), and R8:MTD(8) limitedly suppressed tumor growth when injected i.v. into BalB/C mice bearing CT26 cell-derived tumors. These results indicate that MTD(8) is the minimal killing unit of MTD.

Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.


Noxa; anti-cancer; deleted MTD peptide; tumor suppression

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk